== Adverse effects ==

 
In clinical trials the most common adverse events leading to discontinuation were [[nausea]], [[diarrhea]], and vomiting.<ref>{{cite web |url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020690s037,021720s010,022568s007lbl.pdf |title=www.accessdata.fda.gov |format= |work= |accessdate=}}</ref><ref>{{cite journal |vauthors=Noetzli M, Eap CB | date = Apr 2013 | title = Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease | url = | journal = Clin Pharmacokinet | volume = 52 | issue = 4| pages = 225–41 | doi = 10.1007/s40262-013-0038-9 | pmid = 23408070 }}</ref> Other side effects included difficulty sleeping, muscle cramps and anorexia. Most side effects were observed in patients taking the 23&nbsp;mg dose compared to 10&nbsp;mg or lower doses. Side effects improved with continued use.<ref name="ReferenceA" />

 
In addition to its actions as an acetylcholinesterase inhibitor, donepezil has been found to act as a potent [[agonist]] of the [[sigma-1 receptor|σ<sub>1</sub> receptor]] (K<sub>i</sub> = 14.6 nM), and has been shown to produce specific [[nootropic|antiamnestic]] effects in animals mainly via this action.<ref name="MauriceSu2009">{{cite journal|last1=Maurice|first1=Tangui|last2=Su|first2=Tsung-Ping|title=The pharmacology of sigma-1 receptors|journal=Pharmacology & Therapeutics|volume=124|issue=2|year=2009|pages=195–206|issn=0163-7258|doi=10.1016/j.pharmthera.2009.07.001}}</ref>
